News
Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces the publication of new real-world data that further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback